TARS3
Threonine--tRNA ligase 2, cytoplasmic
Also known as: FLJ25005, SYTC2_HUMAN, TARSL2, ThrRS-L
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A2RTX5
- Gene
- TARS3
- Ensembl
- ENSG00000185418
- Chromosome
- 15
- Canonical length
- 802 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Predicted to enable threonine-tRNA ligase activity. Predicted to be involved in threonyl-tRNA aminoacylation. Predicted to be located in cytoplasm and nucleus. Predicted to be active in mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
802 residues, UniProt reviewed canonical sequence.
>A2RTX5|TARS3
1 MAAEALAAEA VASRLERQEE DIRWLWSEVE RLRDEQLNAP YSCQAEGPCL TREVAQLRAE
61 NCDLRHRLCS LRLCLAEERS RQATLESAEL EAAQEAGAQP PPSQSQDKDM KKKKMKESEA
121 DSEVKHQPIF IKERLKLFEI LKKDHQLLLA IYGKKGDTSN IITVRVADGQ TVQGEVWKTT
181 PYQVAAEISQ ELAESTVIAK VNGELWDLDR PLEGDSSLEL LTFDNEEAQA VYWHSSAHIL
241 GEAMELYYGG HLCYGPPIEN GFYYDMFIED RAVSSTELSA LENICKAIIK EKQPFERLEV
301 SKEILLEMFK YNKFKCRILN EKVNTATTTV YRCGPLIDLC KGPHVRHTGK IKTIKIFKNS
361 STYWEGNPEM ETLQRIYGIS FPDNKMMRDW EKFQEEAKNR DHRKIGKEQE LFFFHDLSPG
421 SCFFLPRGAF IYNTLTDFIR EEYHKRDFTE VLSPNMYNSK LWEASGHWQH YSENMFTFEI
481 EKDTFALKPM NCPGHCLMFA HRPRSWREMP IRFADFGVLH RNELSGTLSG LTRVRRFQQD
541 DAHIFCTVEQ IEEEIKGCLQ FLQSVYSTFG FSFQLNLSTR PENFLGEIEM WNEAEKQLQN
601 SLMDFGEPWK MNPGDGAFYG PKIDIKIKDA IGRYHQCATI QLDFQLPIRF NLTYVSKDGD
661 DKKRPVIIHR AILGSVERMI AILSENYGGK WPFWLSPRQV MVIPVGPTCE KYALQVSSEF
721 FEEGFMADVD LDHSCTLNKK IRNAQLAQYN FILVVGEKEK IDNAVNVRTR DNKIHGEILV
781 TSAIDKLKNL RKTRTLNAEE AFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TARS3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 36 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 36 nTPM
- tongue: 34 nTPM
- spinal cord: 20 nTPM
- midbrain: 18 nTPM
- basal ganglia: 16 nTPM
- hippocampal formation: 16 nTPM
Single-cell type
- oligodendrocytes: 272 nCPM
- thymocytes: 239 nCPM
- innate lymphoid cells: 169 nCPM
- plasma cells: 133 nCPM
- myonuclei: 130 nCPM
- lactotrophs: 127 nCPM
Immune cell
- NK-cell: 7.9 nTPM
- naive B-cell: 7.5 nTPM
- memory CD4 T-cell: 5 nTPM
- memory B-cell: 4.9 nTPM
- naive CD4 T-cell: 4.9 nTPM
- memory CD8 T-cell: 4.3 nTPM
Brain region
- white matter: 64 nTPM
- basal ganglia: 46 nTPM
- pons: 38 nTPM
- cerebellum: 38 nTPM
- medulla oblongata: 37 nTPM
- midbrain: 37 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aminoacyl-tRNA synthetase, class II (G/ P/ S/T)
- Threonine-tRNA ligase, class IIa
- TGS
- Anticodon-binding
- Aminoacyl-tRNA synthetase, class II
- Beta-grasp domain superfamily
- TGS-like
- Threonyl/alanyl tRNA synthetase, SAD
- Threonyl/alanyl tRNA synthetase, class II-like, putative editing domain superfamily
- Threonine-tRNA ligase catalytic core domain
- Anticodon-binding domain superfamily
- Class II Aminoacyl-tRNA synthetase/Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL)
- Threonine-tRNA ligase, class IIa, anticodon-binding domain
- tRNA synthetase class II core domain (G, H, P, S and T)
- TGS domain
- Anticodon binding domain
- Threonyl and Alanyl tRNA synthetase second additional domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TARS3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TARS3 as an antibody target. Whether an autoantibody or antibody against TARS3 could matter depends on whether native TARS3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TARS3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TARS3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...